Atlas Trials

Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

Clinical trial NCT02042170 · COMPLETED

Trial details

NCT number
NCT02042170
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Establishing Dose of Sr-hGH in ISS Patients
Start date
2014-02-01
Primary completion
2015-03-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.